亞精胺 Spermidine × 落髮

結論:台灣市場資訊黑箱

證據強度判為 C(薄弱證據):機轉合理(2011 ex vivo 顯示 spermidine 延長 anagen、上調毛囊上皮幹細胞 K15/K19),且有一份 oral RCT(Rinaldi 2017,n=100,13 週)顯示正面結果,但「所有」spermidine × hair 研究皆由 Tricovel 製造商 Giuliani S.

C 🟠 C 薄弱證據 台灣法規禁言 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 ⚠️ 廠商資助研究

證據強度判為 C(薄弱證據):機轉合理(2011 ex vivo 顯示 spermidine 延長 anagen、上調毛囊上皮幹細胞 K15/K19),且有一份 oral RCT(Rinaldi 2017,n=100,13 週)顯示正面結果,但「所有」spermidine × hair 研究皆由 Tricovel 製造商 Giuliani S.p.A. 資助/執行,8 年來無任何獨立第三方重複試驗。

EFSA 2011 兩份意見書明確否決 hair-related health claims(ID 1705 無因果關係;Article 13(5) Giuliani 申請因屬病理治療被駁回),而 Mayo/Cleveland/Harvard/AAD/ISHRS 五大臨床來源全部 not_addressed — Harvard 連「未經證實之落髮補充品」警示名單(curcumin、ashwagandha、green tea extract)都未納入 spermidine,可見國際皮膚科主流根本未將其視為候選療法。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.50
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 台灣法規禁言
信心度
47%
證據方向分歧
證據層級
E6
多篇較小型隨機對照試驗

各層「支持此療效」的程度

分數越低=該層越不支持
L1 Examine國際基準
0.50
L3 機轉生理合理性
0.50
L5 臨床機構權威立場
0.50
L11 AI 複核獨立判讀
0.50
L2 PubMed原始文獻
0.60
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.503
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

A spermidine-based nutritional supplement prolongs the anagen phase of hair follicles in humans: a randomized, placebo-controlled, double-blind study
PMID: 29214104 2017 RCT (double-blind) n = 100
結論:Treatment group showed significantly increased anagen V-VI HFs and Ki-67 with decreased c-Kit at 3 months vs placebo; pull test remained negative in all supplement recipients at 6 months vs 68% positive in placebo (exact p-values not in abstract).
⚠️ 廠商資助 效應量:~17% increase in anagen phase (vendor-reported); raw between-group SMD not published
前往 PubMed
New multi-targeting strategy in hair growth promotion: in vitro and in vivo studies (N1-methylspermidine + Sandalore topical lotion)
PMID: 29766701 2018 RCT (double-blind) n = 60
結論:Statistically significant reduction in hair loss and increase in hair growth parameters at 3 months; benefits persisted 3 months post-treatment except wash test (specific p-values not in abstract).
⚠️ 廠商資助 效應量:Not reported numerically
前往 PubMed
Spermidine promotes human hair growth and is a novel modulator of human epithelial stem cell functions
PMID: 21818338 2011 In vitro
結論:Spermidine prolonged anagen, promoted hair shaft elongation, and upregulated epithelial stem cell keratins K15/K19 — mechanistic basis for oral Rinaldi 2017 trial.
⚠️ 廠商資助 效應量:Not applicable (mechanistic)
前往 PubMed
Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study
PMID: 34668237 2021 RCT (open-label) n = 100
結論:Intervention reduced telogen density and hair shed (P=0.0465 W8, P=0.0392 W8 vs control); not a spermidine study.
🟠 品質有限 ⚠️ 廠商資助 效應量:Not reported
前往 PubMed

L4a US FDA
中性
At the notifier's request, FDA ceased to evaluate this notice 來源↗
L4b EU EFSA
謹慎
Equivalent of max. 6 mg/day spermidine; Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants, young children, children, adolescents, pregnant and lactating women. The designation of the novel food on the labelling of the foodstuffs containing it shall be 'spermidine-rich wheat germ extract'. 來源↗
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
未表態
— 本適應症無對應資料
L4e WHO
謹慎
Spermidine [in Spermidine trihydrochloride] ... This ingredient cannot be used in natural health products without the submission of additional evidence for safety. 來源↗

L5a NIH Office of Dietary Supplements
中性
— 本適應症無對應資料
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
未表態
— 本適應症無對應資料
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態
— 本適應症無對應資料

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

台灣社群(PTT hair_loss/regimen/MuscleBeach、Dcard、Mobile01、痞客邦、FB 社團)幾乎無「亞精胺 (spermidine) 用於落髮」的真實匿名使用心得。PTT hair_loss 板的落髮討論一面倒集中在 minoxidil(落健)與 finasteride(柔沛/非那雄胺)等實證療法,未見鄉民實測亞精胺生髮;regimen/MuscleBeach 提到的「精氨酸」是不同成分,常被混淆。亞精胺與頭髮的中文網路足跡幾乎全是廠商/部落格行銷內容(遠東生技 febico、formulawave、思思醫師 dr-neil、抗老品牌電商、FB 醫師業配文),引用同一篇 0.5mg/日延長生長期的臨床試驗作賣點,缺乏匿名多人辯證式的在地經驗。屬該 condition 下社群討論極稀少之冷門標的,無共識可供萃取,亦不應杜撰。

💬社群實感

無共識(台灣社群對亞精胺用於落髮幾無真實使用心得;落髮討論集中於 minoxidil 與 finasteride,未見亞精胺實測分享)

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

藻之泌法膠囊 亞精胺 $1,060

代表來源 ↗
L10b · TFDA 法定身份 官方認定

建議每日攝取量200mg小麥粉(含1mg亞精胺)

來源 ↗

  • 針對病因之治療(依掉髮類型鑑別診斷)
  • 移除可逆誘因(停用致病藥物、矯正營養/內分泌失衡、減壓)
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v6 engine_version: v1.0 claim_id: CLM-COND-hair-loss-INT-spermidine-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-hair-loss-INT-spermidine-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "亞精胺能改善落髮",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}